National Institute of Neurological Disorders and Stroke (NINDS)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute of Neurological Disorders and Stroke (NINDS) sits in the top decile of US sponsors by registered trial count (#61 of 15,742 sponsors by registered trial count).
National Institute of Neurological Disorders and Stroke (NINDS): 567 sponsored US clinical trials, 48 recruiting.
National Institute of Neurological Disorders and Stroke (NINDS) sponsors 567 registered US clinical trials on ClinicalTrials.gov, 48 of them currently recruiting, and 467 completed. 16 of these trials are in Phase 3-4 (later-stage) and 158 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 23 trials.
Top-decile sponsor footprint
National Institute of Neurological Disorders and Stroke (NINDS) ranks in the top decile of sponsors by registered trial count (#61 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
467 of 508 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
567 total, page 9 of 12
The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease
NCT00032812
ReoPro and Retavase to Restore Brain Blood Flow After Stroke
NCT00039832
Brain Anatomy in Dystonia
NCT00031369
GABA Levels in the Brains of Blind People
NCT00357409
Cause, Development, and Progression of Stiff-Person Syndrome
NCT00030940
Magnetic Resonance Spectroscopy to Evaluate Tourette s Syndrome
NCT00030953
Immune Abnormalities in Sporadic Inclusion Body Myositis
NCT00030212
Brain Control of Blinking
NCT00030199
Donepezil to Treat Dementia in Parkinson's Disease
NCT00030979
Imaging Study of Automatic Movements
NCT00031382
Brain Activity During Production of Movement
NCT00029939
Interhemispheric Interactions Associated With Performance of Voluntary Movements in Patients With Stroke Motor Disability
NCT00029718
Surround Inhibition in Patients With Dystonia
NCT00029601
Effect of Transcranial Magnetic Stimulation on Free Will
NCT00029653
Data Collection in Women With Fabry Disease
NCT00030134
Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease
NCT00029666
Role of Brain Region Changes in Tactile (Touch) Ability Following Nerve Block
NCT00357058
Brain Control of Bimanual (Both Hands) Movements
NCT00029302
Comparison of Externally and Self-Initiated Movements
NCT00028197
Enhancement of Use-Dependent Plasticity by Somatosensory Stimulation in Chronic Stroke
NCT00028379
Enhanced Tactile (Touch) Spatial Acuity in Upper Limb Amputees
NCT00028210
Role of the Intact Hemisphere in Recovery of Motor Function After Stroke
NCT00028184
Temperature Response to a Head-Neck Cooling System
NCT00025987
Brain Activation in Vocal and Motor Tics
NCT00026000
Study of Specimens Obtained During Epilepsy Surgery
NCT00025714
EEG and EMG Studies of Hand Dystonia
NCT00025701
Test of A Model of Representational Knowledge Stored in the Human Prefrontal Cortex
NCT00024908
EEG and EMG Analysis of Ideomotor Apraxia
NCT00024999
Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease
NCT00026598
Electrical Stimulation to Improve Hand Function in Patients With Chronic Stroke
NCT00023569
Eye-Hand Coordination in Children With Spastic Diplegia
NCT00024791
Transcranial Magnetic Stimulation in Parkinson's Disease
NCT00023062
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
NCT00023075
Motor Training to Treat Hand Dystonia
NCT00021853
Motor Learning in Stroke Patients and Healthy Volunteers
NCT00021710
Genetic Analysis of the Chiari I Malformation
NCT00004738
Phenotype/Genotype Correlations in Neuromuscular Disorders
NCT00017745
Transcranial Magnetic Stimulation (TMS) Studies of Dystonia
NCT00017875
Study of Brain Control of Movement
NCT00017979
Brain Excitability During Self-Paced Voluntary Movements
NCT00017966
Cause and Pathogenesis of Neurometabolic Disorders
NCT00016562
Screening and Natural History: Primary Lateral Sclerosis and Related Disorders
NCT00015444
Evaluation and Treatment of Patients With Epilepsy
NCT00013845
Language Stimuli Screening in Children
NCT00016796
Safety Study of Idebenone to Treat Friedreich's Ataxia
NCT00015808
Differences in Brain Processing of First and Second Languages (Korean and English)
NCT00016510
1-Octanol to Treat Essential Tremor
NCT00016679
Study of Air Stream in Voice Production
NCT00015795
The Natural History and Pathogenesis of Mucolipidosis Type IV
NCT00015782
Diagnostic Evaluation of Patients With Neuromuscular Disease
NCT00015470
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 78 |
| Phase 3 | 11 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the National Institute of Neurological Disorders and Stroke (NINDS) pipeline
48 recruiting of 567 indexed (8% open); 467 completed (82%).
Phase mix: 16 late (III/IV) vs 158 early (I/II) (early-phase heavy).
Top condition: Healthy (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute of Neurological Disorders and Stroke (NINDS): open-pipeline peers nationwide
Peers matched on 567 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
National Institute of Neurological Disorders and Stroke (NINDS) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 567 trials (± recruiting share)
- Children's Hospital Medical Center, Cincinnati · 571 trials · 19% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
Sponsors near 8% open enrollment (± trial volume)
- National Jewish Health · 8% recruiting · 83 trials
- ACADIA Pharmaceuticals · 9% recruiting · 35 trials
- Texas Tech University Health Sciences Center, El Paso · 9% recruiting · 35 trials
- Boehringer Ingelheim · 8% recruiting · 515 trials
Related
What to do with this National Institute of Neurological Disorders and Stroke (NINDS) page
567 registered trials is a research-attention snapshot, not an endorsement of National Institute of Neurological Disorders and Stroke (NINDS) or any single study.
- 48 of National Institute of Neurological Disorders and Stroke (NINDS)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institute of Neurological Disorders and Stroke (NINDS) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. National Institute of Neurological Disorders and Stroke (NINDS) pipeline card: 567 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.